| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |